MPA Pharma is an owner-managed, internationally active and dynamically growing company with core competences in the areas of re-import and parallel import of EU medicinal products, trade-in of medicinal products and medical devices as well as contract manufacturing for third-party companies. As one of the market leaders, the company has over 35 years of experience and expertise in the pharmaceutical market. MPA Pharma is the wholly owned parent company of the distribution company EMRAmed, which is based in Germany and has business activities in German-speaking countries. Since 2016, the MPA Pharma Group has also been a 100 per cent shareholder in the Scandinavian Paranova Group A/S, which is based in Denmark and has sales activities in Denmark, Sweden, Finland and Norway.